XCRP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XCRP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-19), Xcorporeal's share price is $0.0001. Xcorporeal's Tangible Book per Share of Sep. 2009 for the quarter that ended in Sep. 2009 was $-0.20. Hence, Xcorporeal's Price to Tangible Book Ratio of today is .
The historical rank and industry rank for Xcorporeal's Price-to-Tangible-Book or its related term are showing as below:
A closely related ratio is called PB Ratio. As of today, Xcorporeal's share price is $0.0001. Xcorporeal's Book Value per Sharefor the quarter that ended in Sep. 2009 was $-0.20. Hence, Xcorporeal's P/B Ratio of today is .
The historical data trend for Xcorporeal's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xcorporeal Annual Data | |||||||||||||||||||||
Trend | Feb99 | Feb00 | Dec01 | Dec02 | Dec03 | Dec04 | Dec05 | Dec06 | Dec07 | Dec08 | |||||||||||
Price-to-Tangible-Book | Get a 7-Day Free Trial | - | - | 0.02 | 4.67 | - |
Xcorporeal Quarterly Data | ||||||||||||||||||||
Dec04 | Mar05 | Jun05 | Sep05 | Dec05 | Mar06 | Jun06 | Sep06 | Dec06 | Mar07 | Jun07 | Sep07 | Dec07 | Mar08 | Jun08 | Sep08 | Dec08 | Mar09 | Jun09 | Sep09 | |
Price-to-Tangible-Book | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Devices subindustry, Xcorporeal's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Xcorporeal's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Xcorporeal's Price-to-Tangible-Book falls into.
Xcorporeal's price-to-tangible-book ratio for today is calculated as:
Price to Tangible Book | = | Share Price | / | Tangible Book per Share (Q: Sep. 2009 ) |
= | 0.0001 | / | -0.2 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price to Tangible Book | = | Market Cap | / | Tangible Equity | ||||
= | Market Cap | / | (Total Stockholders Equity | - | Preferred Stock | - | Intangible Assets) |
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Thank you for viewing the detailed overview of Xcorporeal's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Kelly J. Mccrann | director, officer: Chairman and CEO | 11150 SANTA MONICA BLVD #1500, LOS ANGELES CA 90025 |
Daniel S Goldberger | officer: Chief Executive Officer | 24 CARPENTER ROAD, CHESTER NY 10918 |
Marc G Cummins | director | C/O PRIME LOGIC CAPITAL, LLC, 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022 |
Prime Logic Capital, Llc | 10 percent owner | 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022 |
Robert Weinstein | officer: Chief Financial Officer | 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169 |
Terren S Peizer | director, 10 percent owner, officer: Executive Chairman | 11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025 |
Jay Wolf | director | 981 LINDA FLORA DRIVE, LOS ANGELES, CA 90049 |
Herve De Kergrohen | director | 22 CHEMIN DU NANTET, COLLONGE-BELLERIVE V8 CH1245 |
Nicholas Sheridan Lewin | director | 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019 |
Lawrence Lacerte | 10 percent owner | C/O TERAGLOBAL COMMUNICATIONS CORP, 9171 TOWNE CENTRE DRIVE SUITE 600, SAN DIEGO CA 92122 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.